PharmaBiome and Roquette team up to design brand new nutrition and health ingredients targeting an optimal interaction with gut microbiota to contribute to a healthy diet. The two partners will use PharmaBiome’s proprietary technology, the NicheMap. This method allows the screening and the formulation of innovative prebiotic solutions using novel soluble fibers developed by Roquette.
The use of different fibers by selective bacteria induces the production of molecules – metabolites – that will impact the host’s health. These fibers are qualified as prebiotics. To optimize the health benefits of a fiber, it is essential to understand how gut bacteria use their substrates and what the produced molecules are. Knowing the structural characteristics that make a prebiotic out of a fiber is key to produce new ingredients with specific health properties.
PharmaBiome is a biotech company with a deep understanding of the link between microbiome composition and function. They use their unique predictive microbiome technology NicheMapTM, and they have demonstrated strong capabilities to predict the effect of prebiotic fibers on both microbial composition and activity in the human gut.
Roquette aims at helping people to close the fiber gap with fiber ingredients easy to use for complementing consumers’ daily diets through fiber enrichment and supplement. Roquette, a global leader in plant-based ingredients, has been working with PharmaBiome since July 2017. The group has previously used and approved the said technology on existing and prototyped fiber ingredients.
Partnership enters a new phase
Dr. Tomas de Wouters, CEO of PharmaBiome, stated: "This project is an important milestone in our long-term collaboration with Roquette taking the leap from understanding the effect of fibers to using our insights to develop and optimize fiber products. Our long-standing collaboration with Roquette is a great validation of the biological relevance of our NicheMapTM technology, expanding our understanding of the microbiome and its use in the field of prebiotics.”
Dr. Laetitia Guérin-Deremaux, Head of Nutrition and Health R&D at Roquette, said: “This project with PharmaBiome will allow Roquette to offer new microbiome-targeted fibers with scientifically proven health benefits. We are very pleased by the results of this continued collaboration which reinforces our commitment to delivering plant-based innovative ingredients to the food, nutrition and health sectors.”
Roquette is a family-owned global leader in plant-based ingredients, a pioneer of plant proteins and a leading provider of pharmaceutical excipients. Founded in 1933, the company currently operates in more than 100 countries, has a turnover of 3.9 billion euros, and employs more than 8,000 people worldwide.
Backed by more than 20 years of proprietary scientific evidence in the field of soluble fibers, Roquette has developed the NUTRIOSE soluble fiber range for several years. These ingredients contribute to selectively modulate the gut microbiota towards a healthier composition. Several studies have demonstrated the benefits of NUTRIOSE on blood sugar management, digestive health, satiety and sustained energy release. The overall results show that NUTRIOSE meets the requirements of the definition of a prebiotic as defined by ISAPP (International Scientific Association for Probiotics and Prebiotics). This partnership will be a key lever to extend the current fiber range.
(Press release / SK)
Picture: Fotolia / TL Furrer
Please login or sign up to comment.
Commenting guidelines